Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
Xanax 500 microgram Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Pink, oval, biconvex tablet scored on one side and marked “Upjohn 55” on the other. |
Each tablet contains 500 micrograms alprazolam.
Excipient(s) with known effect: Lactose, 91.1 mg per tablet.
For the full list of excipients, see section 6.1
| Active Ingredient | Description | |
|---|---|---|
| Alprazolam |
Alprazolam, like other benzodiazepines, has a high affinity for the benzodiazepine binding site in the brain. It facilitates the inhibitory neurotransmitter action of gamma-aminobutyric acid, which mediates both pre- and post synaptic inhibition in the central nervous system (CNS). |
| List of Excipients |
|---|
|
Lactose |
Clear PVC/aluminium foil blister strips of 10 tablets, packed 6 strips to a box.
Glass bottle with metal screw cap or HDPE bottle with LDPE tamper evident cap containing 100 or 1000 tablets.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
PL 00057/1059
Date of first authorisation: 27 August 1982
Date of latest renewal: 23 January 2003
| Drug | Countries | |
|---|---|---|
| XANAX | Canada, Cyprus, Ecuador, Estonia, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
